Australia Clears Novartis Buy Of Alcon Without Key Eye-care Line
This article was originally published in PharmAsia News
Executive Summary
Australian authorities have given their permission for the merger of Switzerland's Novartis AG and Alcon Laboratories, based in the United States, but incorporated in Switzerland